Direct-Acting Antivirals against Hepatitis C
Academic Press Inc (Verlag)
978-0-443-41363-6 (ISBN)
- Noch nicht erschienen (ca. Mai 2026)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Direct-Acting Antivirals against Hepatitis C: Current Issues and Future Perspectives is a comprehensive and indispensable resource for anyone involved in the management of Chronic Hepatitis C. With its in-depth exploration of DAAs, from their molecular mechanisms to their clinical applications and future directions, this book equips clinicians, researchers, and students with the knowledge and insights needed to enhance their practices and contribute to the global fight against HCV infection.
Mohamed El-Kassas, a distinguished figure in hepatology, held prestigious positions in global medical organizations such as IASL, AHPBCC, WGO, Global NASH Council, and SLMENA. He has also held administrative roles in EARTH and the Egyptian National Committee for the Control of Viral Hepatitis. With a PG Diploma in Clinical Research, he received awards and recognition for his research, including the Best Arab Researcher Prize in Natural Sciences. He has published over 200 peer-reviewed manuscripts and served on the editorial boards of journals like PLOS One, Frontiers, and JCTH. He also reviewed for over 70 international journals, contributing to the field of hepatology.
Section 1. Direct-Acting Antivirals (DAAs) in Hepatitis C
1. Hepatitis C Virus Overview
2. HCV-Host Interactions: Virus specific factors, virus host related determinants, and Intracellular Signaling
3. Introduction to Direct-Acting Antivirals: Mechanisms of Action and different classes
Section 2. Therapeutic Strategies and Clinical Applications of DAAs in managing HCV
4. Clinical Efficacy of different DAAs regimens
5. Safety and tolerability of different DAAs regimens
6. Benefits of treating HCV by DAAs beyond virological response
7. Current landscape and guidelines of DAAs treatment in general population
8. Individualized treatment approaches in various special patient populations
Section 3. Challenges and Future Directions in DAA Therapy
9. Antiviral Resistance in Hepatitis C and DAA Therapy
10. DAA Therapy and hepatocellular carcinoma
11. Limitations and unmet needs in DAAs therapy
12. Emerging Therapeutic Strategies and Future Directions
13. Access to DAAs therapy, and role of DAAs in targeted HCV elimination
| Erscheint lt. Verlag | 1.5.2026 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 450 g |
| Themenwelt | Naturwissenschaften ► Biologie |
| ISBN-10 | 0-443-41363-0 / 0443413630 |
| ISBN-13 | 978-0-443-41363-6 / 9780443413636 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich